An Open Label, Multicenter Study to Evaluate the Pharmacokinetics, Efficacy and Safety of ASCENIV ™ (IGIV) in Pediatric Subjects With Primary Immunodeficiency Diseases (PIDD)
Condition:   Primary Immune Deficiency Intervention:   Biological: Asceniv™ Sponsor:   ADMA Biologics, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 7, 2021 Category: Research Source Type: clinical trials

Systematic Screening for Primary Immunodeficiencies in Patients Admitted for Severe Infection in Pediatric Intensive Care Unit
Conditions:   Severe Infection;   Severe Immune Deficiency Intervention:   Sponsor:   University Hospital, Montpellier Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 5, 2021 Category: Research Source Type: clinical trials